Thursday, January 17, 2019

2 hours ago - The Food and Drug Administration has been scrutinizing drug compounders through its 2018 Compounding Policy Priorities Plan, which aims to improve the quality and sterility standards and avoid the repeat of a 2012 fungal meningitis outbreak which caused 750 cases of illness and 60 deaths across 20 states.

No comments: